Clay Cauthen

575 total citations
15 papers, 459 citations indexed

About

Clay Cauthen is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Surgery. According to data from OpenAlex, Clay Cauthen has authored 15 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Clay Cauthen's work include Heart Failure Treatment and Management (7 papers), Cardiovascular Function and Risk Factors (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). Clay Cauthen is often cited by papers focused on Heart Failure Treatment and Management (7 papers), Cardiovascular Function and Risk Factors (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). Clay Cauthen collaborates with scholars based in United States, Peru and Italy. Clay Cauthen's co-authors include W.H. Wilson Tang, Vijaiganesh Nagarajan, Randall C. Starling, Vicente A. Benítes-Zapata, Antonio Abbate, George W. Vetrovec, Adrían V. Hernández, Michael J. Lipinski, Wilson Tong and Anil Jain and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

Clay Cauthen

13 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clay Cauthen United States 7 216 128 91 82 73 15 459
Özgür Akgül Türkiye 14 234 1.1× 95 0.7× 80 0.9× 83 1.0× 87 1.2× 36 490
Ahmet Göktuğ Ertem Türkiye 12 254 1.2× 89 0.7× 102 1.1× 57 0.7× 108 1.5× 62 520
Janusz Szkodziński Poland 13 255 1.2× 148 1.2× 117 1.3× 47 0.6× 72 1.0× 46 490
Jia‐Rou Liu Taiwan 16 345 1.6× 46 0.4× 110 1.2× 73 0.9× 80 1.1× 36 652
Cheng-Hsueh Wu Taiwan 11 146 0.7× 40 0.3× 158 1.7× 56 0.7× 59 0.8× 22 454
Ahmet Çamsarı Türkiye 13 409 1.9× 58 0.5× 148 1.6× 90 1.1× 56 0.8× 41 664
Zhijun Sun China 12 166 0.8× 80 0.6× 60 0.7× 58 0.7× 57 0.8× 36 353
Kim E. Jie Netherlands 11 89 0.4× 70 0.5× 58 0.6× 88 1.1× 82 1.1× 20 613
Keith Sai Kit Leung United Kingdom 15 288 1.3× 147 1.1× 89 1.0× 94 1.1× 51 0.7× 41 645
Péter Galajda Slovakia 13 261 1.2× 33 0.3× 112 1.2× 63 0.8× 84 1.2× 78 546

Countries citing papers authored by Clay Cauthen

Since Specialization
Citations

This map shows the geographic impact of Clay Cauthen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clay Cauthen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clay Cauthen more than expected).

Fields of papers citing papers by Clay Cauthen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clay Cauthen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clay Cauthen. The network helps show where Clay Cauthen may publish in the future.

Co-authorship network of co-authors of Clay Cauthen

This figure shows the co-authorship network connecting the top 25 collaborators of Clay Cauthen. A scholar is included among the top collaborators of Clay Cauthen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clay Cauthen. Clay Cauthen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cauthen, Clay, et al.. (2022). FINANCIAL TOXICITY IN PATIENTS WITH CHRONIC HEART FAILURE. Journal of the American College of Cardiology. 79(9). 472–472. 3 indexed citations
2.
Montaño, Sergio, et al.. (2022). AN OFF-LABEL LIFESAVER: TRANSCATHETER MITRAL VALVE REPAIR FOR SEVERE MITRAL REGURGITATION ASSOCIATED WITH HYPERTROPHIC CARDIOMYOPATHY. Journal of the American College of Cardiology. 79(9). 2806–2806.
3.
Balan, Prakash, et al.. (2021). VALIDATION OF THE CARDIAC ARREST SURVIVAL SCORE IN AN URBAN POPULATION OF OUT-OF-HOSPITAL CARDIAC ARRESTS. Journal of the American College of Cardiology. 77(18). 1144–1144.
4.
Tecson, Kristen M., Marc A. Silver, Clay Cauthen, et al.. (2016). Impact of Enhanced External Counterpulsation on Heart Failure Rehospitalization in Patients With Ischemic Cardiomyopathy. The American Journal of Cardiology. 117(6). 901–905. 6 indexed citations
5.
Nagarajan, Vijaiganesh, Adrían V. Hernández, Clay Cauthen, Randall C. Starling, & W.H. Wilson Tang. (2016). Usefulness of cell-mediated immune function in risk stratification for patients with advanced heart failure. American Heart Journal. 183. 35–39. 3 indexed citations
6.
Benítes-Zapata, Vicente A., Adrían V. Hernández, Vijaiganesh Nagarajan, et al.. (2014). Usefulness of Neutrophil-to-Lymphocyte Ratio in Risk Stratification of Patients With Advanced Heart Failure. The American Journal of Cardiology. 115(1). 57–61. 118 indexed citations
7.
Nagarajan, Vijaiganesh, Clay Cauthen, & W.H. Wilson Tang. (2013). LACK OF PROGNOSTIC VALUE OF PLATELET MARKERS IN PATIENTS WITH ADVANCED HEART FAILURE. Journal of the American College of Cardiology. 61(10). E747–E747. 3 indexed citations
8.
Nagarajan, Vijaiganesh, Clay Cauthen, & W.H. Wilson Tang. (2013). Abstract 255: Neutrophil-to-Eosinophil Ratio Predicts Mortality in Patients with Advanced Heart Failure. Circulation Cardiovascular Quality and Outcomes. 6(suppl_1). 1 indexed citations
9.
Nagarajan, Vijaiganesh, Clay Cauthen, Randall C. Starling, & W.H. Wilson Tang. (2013). Prognosis of Morbid Obesity Patients With Advanced Heart Failure. Congestive Heart Failure. 19(4). 160–164. 41 indexed citations
10.
Cauthen, Clay, Wilson Tong, Anil Jain, & W.H. Wilson Tang. (2011). Progressive Rise in Red Cell Distribution Width Is Associated With Disease Progression in Ambulatory Patients With Chronic Heart Failure. Journal of Cardiac Failure. 18(2). 146–152. 48 indexed citations
11.
Cauthen, Clay, Matthew Tong, Yuping Wu, Anil Jain, & W.H. Wilson Tang. (2011). Prognostic Importance of Serial Evaluation of Blood Urea Nitrogen in Ambulatory Patients with Chronic Systolic Heart Failure and Preserved Renal Function. Journal of Cardiac Failure. 17(8). S86–S86. 1 indexed citations
12.
Lipinski, Michael J., Clay Cauthen, Giuseppe Biondi‐Zoccai, et al.. (2009). Meta-Analysis of Randomized Controlled Trials of Statins Versus Placebo in Patients With Heart Failure. The American Journal of Cardiology. 104(12). 1708–1716. 78 indexed citations
13.
Cauthen, Clay, Michael J. Lipinski, Antonio Abbate, et al.. (2008). Relation of Blood Urea Nitrogen to Long-Term Mortality in Patients With Heart Failure. The American Journal of Cardiology. 101(11). 1643–1647. 76 indexed citations
14.
Cauthen, Clay, et al.. (2001). Comparative analysis of the expression patterns of Wnts and Frizzleds during early myogenesis in chick embryos. Mechanisms of Development. 104(1-2). 133–138. 41 indexed citations
15.
Baldwin, William S., S W Curtis, Clay Cauthen, et al.. (1998). BG-1 ovarian cell line: An alternative model for examining estrogen-dependent growth in vitro. In Vitro Cellular & Developmental Biology - Animal. 34(8). 649–654. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026